Alzamend Neuro Inc. (ALZN): Major Movement on the Horizon – Invest Chronicle

Alzamend Neuro Inc. (ALZN): Major Movement on the Horizon

At the end of the latest market close, Alzamend Neuro Inc. (ALZN) was valued at $1.84. In that particular session, Stock kicked-off at the price of $1.88 while reaching the peak value of $1.92 and lowest value recorded on the day was $1.81. The stock current value is $1.85.Recently in News on January 13, 2022, ALZN: Coordinated Offensive on Alzheimer’s Disease. By John Vandermosten, CFA. You can read further details here

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Alzamend Neuro Inc. shares are logging -94.49% during the 52-week period from high price, and 4.53% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.77 and $33.55.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3081337 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Alzamend Neuro Inc. (ALZN) recorded performance in the market was -3.16%, having the revenues showcasing -25.51% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 167.72M, as it employees total of 2 workers.

The Analysts eye on Alzamend Neuro Inc. (ALZN)

During the last month, 0 analysts gave the Alzamend Neuro Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 2.3994, with a change in the price was noted -1.42. In a similar fashion, Alzamend Neuro Inc. posted a movement of -43.16% for the period of last 100 days, recording 5,333,690 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ALZN is recording 0.02 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

>> 7 Top Picks for the Post-Pandemic Economy << 

Technical rundown of Alzamend Neuro Inc. (ALZN)

Raw Stochastic average of Alzamend Neuro Inc. in the period of last 50 days is set at 6.21%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.87%. In the last 20 days, the company’s Stochastic %K was 7.58% and its Stochastic %D was recorded 7.09%.

Considering, the past performance of Alzamend Neuro Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -3.16%. The shares increased approximately by -7.54% in the 7-day charts and went up by -23.33% in the period of the last 30 days. Common stock shares were lifted by -25.51% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts